HIV-1 entry inhibitors in the side pocket

被引:84
作者
Sodroski, JG [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
D O I
10.1016/S0092-8674(00)81655-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:243 / 246
页数:4
相关论文
共 18 条
[1]   EFFECTS OF AMINO-ACID CHANGES IN THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 ENVELOPE GLYCOPROTEIN [J].
CAO, J ;
BERGERON, L ;
HELSETH, E ;
THALI, M ;
REPKE, H ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2747-2755
[2]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[3]   Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].
Chan, DC ;
Chutkowski, CT ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617
[4]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[5]   MUTATIONS IN THE LEUCINE ZIPPER OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN AFFECT FUSION AND INFECTIVITY [J].
DUBAY, JW ;
ROBERTS, SJ ;
BRODY, B ;
HUNTER, E .
JOURNAL OF VIROLOGY, 1992, 66 (08) :4748-4756
[6]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[7]  
Ferrer M, 1999, NAT STRUCT BIOL, V6, P953
[8]   Capture of an early fusion-active conformation of HIV-1 gp41 [J].
Furuta, RA ;
Wild, CT ;
Weng, YK ;
Weiss, CD .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :276-279
[9]   HIV-1 INHIBITION BY A PEPTIDE [J].
JIANG, SB ;
LIN, K ;
STRICK, N ;
NEURATH, AR .
NATURE, 1993, 365 (6442) :113-113
[10]   Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].
Kilby, JM ;
Hopkins, S ;
Venetta, TM ;
DiMassimo, B ;
Cloud, GA ;
Lee, JY ;
Alldredge, L ;
Hunter, E ;
Lambert, D ;
Bolognesi, D ;
Mathews, T ;
Johnson, MR ;
Nowak, MA ;
Shaw, GM ;
Saag, MS .
NATURE MEDICINE, 1998, 4 (11) :1302-1307